乐心医疗
(300562)
| 流通市值：22.36亿 | | | 总市值：30.14亿 |
| 流通股本：1.62亿 | | | 总股本：2.19亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 521,364,786.34 | 273,307,188.91 | 983,982,436.12 | 756,340,201.33 |
| 营业收入 | 521,364,786.34 | 273,307,188.91 | 983,982,436.12 | 756,340,201.33 |
| 二、营业总成本 | 470,355,356.57 | 246,632,304.47 | 908,152,076.03 | 698,416,206.35 |
| 营业成本 | 338,865,245.07 | 171,149,117.44 | 638,873,788.26 | 482,104,867.66 |
| 税金及附加 | 3,976,047.66 | 1,960,770.95 | 7,875,594.37 | 6,018,472.42 |
| 销售费用 | 42,311,401.59 | 26,880,221.09 | 93,808,201.62 | 80,693,000 |
| 管理费用 | 36,329,402.08 | 22,739,145.77 | 88,443,748.31 | 62,741,488.19 |
| 研发费用 | 49,957,539.37 | 26,345,008.64 | 96,807,528.07 | 74,604,037.68 |
| 财务费用 | -1,084,279.2 | -2,441,959.42 | -17,656,784.6 | -7,745,659.6 |
| 其中:利息费用 | 1,598,440.73 | 819,716.08 | 5,346,679.63 | 2,616,202.63 |
| 其中:利息收入 | 2,703,077.82 | 781,204.57 | 7,349,831.58 | 5,857,930.69 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 194,305.79 | 1,306,601.23 | -136,535.03 | -4,109,938.26 |
| 加:投资收益 | 3,123,644.26 | -702,911.05 | 302,371.39 | 649,977.75 |
| 资产处置收益 | -150,131.33 | 49,062.26 | 90,332.76 | -83,938.47 |
| 资产减值损失(新) | -5,714,429.83 | - | -19,326,754.33 | -2,244,438.35 |
| 信用减值损失(新) | -5,939,668.22 | -3,935,111.3 | -1,216,344.28 | -5,478,539.72 |
| 其他收益 | 1,555,731.01 | 665,150.22 | 2,877,223.94 | 2,895,895.19 |
| 四、营业利润 | 44,078,881.45 | 24,057,675.8 | 58,420,654.54 | 49,553,013.12 |
| 加:营业外收入 | 109,459.32 | 2,001.7 | 2,148,817.81 | 778,073.04 |
| 减:营业外支出 | 62,951.95 | 52,374.44 | 530,001.04 | 476,859.49 |
| 五、利润总额 | 44,125,388.82 | 24,007,303.06 | 60,039,471.31 | 49,854,226.67 |
| 减:所得税费用 | 2,874,102.54 | 1,221,307.27 | 1,883,240.86 | 1,668,135.36 |
| 六、净利润 | 41,251,286.28 | 22,785,995.79 | 58,156,230.45 | 48,186,091.31 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 41,251,286.28 | 22,785,995.79 | 58,156,230.45 | 48,186,091.31 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 42,290,430.52 | 22,942,005.96 | 61,364,226.27 | 50,527,301.98 |
| 少数股东损益 | -1,039,144.24 | -156,010.17 | -3,207,995.82 | -2,341,210.67 |
| 扣除非经常损益后的净利润 | 38,070,928.81 | 20,648,884.66 | 55,977,498.26 | 49,949,778.06 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.19 | 0.11 | 0.28 | 0.23 |
| (二)稀释每股收益 | 0.19 | 0.11 | 0.28 | 0.23 |
| 八、其他综合收益 | -812,328.02 | -641.48 | -54,794,563.4 | 119,633.15 |
| 归属于母公司股东的其他综合收益 | -812,328.02 | -641.48 | -54,794,563.4 | 119,633.15 |
| 九、综合收益总额 | 40,438,958.26 | 22,785,354.31 | 3,361,667.05 | 48,305,724.46 |
| 归属于母公司股东的综合收益总额 | 41,478,102.5 | 22,941,364.48 | 6,569,662.87 | 50,646,935.13 |
| 归属于少数股东的综合收益总额 | -1,039,144.24 | -156,010.17 | -3,207,995.82 | -2,341,210.67 |
| 公告日期 | 2025-08-16 | 2025-04-26 | 2025-03-29 | 2024-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |